Understanding Glucosamine and Chondroitin

Course #98090 - $15 -


Study Points

  1. Identify and describe the forms of glucosamine and chondroitin available on the market.
  2. Review the evidence for the use of glucosamine and chondroitin for common conditions.
  3. Discuss the potential safety concerns with glucosamine and chondroitin.

    1 . The glucosamine base used in supplements has most commonly been derived from
    A) the exoskeletons of shellfish, such as shrimp, lobster, and crabs.
    B) Aspergillus.
    C) fermented corn.
    D) animal cartilage.

    AN OVERVIEW OF GLUCOSAMINE

    Glucosamine supplements are available in three different salt forms: glucosamine sulfate, glucosamine hydrochloride, and N-acetyl glucosamine. The glucosamine base used in supplements has most commonly been derived from the exoskeletons of shellfish, such as shrimp, lobster, and crabs. However, glucosamine can also be created synthetically or obtained from Aspergillus or fermented corn [1].

    Click to Review



    2 . Which available form of glucosamine has been only minimally evaluated in clinical research?
    A) Glucosamine hydrochloride
    B) Glucosamine sulfate
    C) L-acetyl glucosamine
    D) N-acetyl glucosamine

    AN OVERVIEW OF GLUCOSAMINE

    N-acetyl glucosamine, the acetylated derivative of glucosamine, is the least common form found in supplements. This form of glucosamine has not been extensively studied in clinical research; most of the evidence around the use of glucosamine supplements is for the sulfate and hydrochloride salts [5].

    Click to Review



    3 . How would you describe the evidence for the use of glucosamine for knee osteoarthritis to a colleague?
    A) Glucosamine salts do not appear to be beneficial despite a large body of research.
    B) Glucosamine sulfate seems to modestly reduce pain and improve function.
    C) Glucosamine salts do not seem to improve symptoms but may reduce disease progression.
    D) Glucosamine hydrochloride provides benefits similar to NSAIDS, with a more rapid onset.

    REVIEWING THE EVIDENCE

    Most research has focused on the use of oral glucosamine sulfate for the management of knee osteoarthritis. A very limited amount of research has been conducted in hip and spine osteoarthritis, with inconclusive findings [7].

    When used for knee osteoarthritis, meta-analyses of the available research show that taking glucosamine sulfate 1,500 mg daily for up to three years modestly improves pain and function when compared with placebo. Individual studies have shown a 28% to 41% pain reduction and 21% to 46% improvement in function [3,8,9,10,11,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30].

    Click to Review



    4 . In small studies comparing glucosamine sulfate with NSAIDs for the treatment of osteoarthritis-related pain,
    A) NSAIDs appear to relieve symptoms within two weeks, whereas glucosamine sulfate can take four to eight weeks.
    B) Glucosamine sulfate appear to relieve symptoms within two weeks, whereas NSAIDs can take four to eight weeks.
    C) Glucosamine demonstrated a failure to relieve symptoms in most patients.
    D) Glucosamine had a poorer side effect profile than NSAIDs in these patients.

    REVIEWING THE EVIDENCE

    Small studies comparing glucosamine sulfate with nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen 400 mg three times daily or piroxicam 20 mg daily, suggest that these treatments provide similar benefit. However, NSAIDs appear to relieve symptoms within two weeks, whereas glucosamine sulfate can take four to eight weeks [12,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30].

    Click to Review



    5 . What is the most likely reason that some experts recommend the use of only pharmaceutical-grade glucosamine and chondroitin products?
    A) These products are the only ones considered to be safe.
    B) These products are more affordable than other supplement products.
    C) Products that are not pharmaceutical-grade can be expected to have quality issues.
    D) Studies evaluating pharmaceutical-grade products have yielded consistently positive results.

    REVIEWING THE EVIDENCE

    To date, the most consistent positive evidence for glucosamine sulfate has been seen with Dona, a specific crystalline glucosamine sulfate product that has been sold as a prescription in some countries and is thus often referred to as "pharmaceutical-grade." In fact, some studies with this product have shown that it can prevent joint space narrowing of greater than 0.5 mm by up to 54% when compared with placebo. Studies using other glucosamine sulfate products have yielded conflicting findings related to disease progression [1,13,15].

    Click to Review



    6 . For the management of knee osteoarthritis, research indicates that glucosamine hydrochloride
    A) is less effective than glucosamine sulfate.
    B) is more effective than glucosamine sulfate.
    C) is equally effective as glucosamine sulfate.
    D) is the preferred option, as demonstrated by multiple high-quality studies.

    REVIEWING THE EVIDENCE

    In contrast to the generally positive findings related to the use of glucosamine sulfate for knee osteoarthritis, glucosamine hydrochloride has shown no real benefit in clinical research.

    A meta-analysis of the available research shows that taking glucosamine hydrochloride 1,500 mg daily for up to 18 months does not seem to reduce pain when compared with placebo. Research on the use of glucosamine hydrochloride in combination with chondroitin sulfate has yielded conflicting findings. Some research has found that taking this combination is non-inferior to celecoxib 200 mg daily for relieving pain, but not for improving stiffness or function. Other research has shown no benefit. It is possible that any benefit identified from this combination may be due to chondroitin sulfate [15,24,31,32,33,34].

    Although the research indicates that glucosamine hydrochloride is less effective than glucosamine sulfate for the management of knee osteoarthritis, head-to-head trials comparing these two salt forms are lacking. It has been proposed that the bioavailability of glucosamine from glucosamine hydrochloride may be reduced in comparison to pharmaceutical-grade crystalline glucosamine sulfate, but more research is needed to confirm [15,24,31,32,33,34].

    Click to Review



    7 . What can be said about the available data for the use of chondroitin sulfate for knee osteoarthritis?
    A) Chondroitin sulfate does not seem to improve symptoms but may reduce disease progression.
    B) Research shows that chondroitin sulfate may only be beneficial for other forms of osteoarthritis.
    C) Chondroitin sulfate may modestly reduce pain, disability, and joint degeneration and narrowing.
    D) Research suggests that chondroitin sulfate is only beneficial when used in combination with glucosamine.

    REVIEWING THE EVIDENCE

    Chondroitin sulfate, when taken alone, has demonstrated modest benefit for reducing pain and improving function in some patients with knee osteoarthritis. Meta-analyses of the available research show that taking chondroitin sulfate 800–2,000 mg in single or divided doses daily for at least three months can modestly reduce pain and disability when compared with placebo [11,22,23,30,35,36,37,38,39,40,41,42,43,44,45,46]. Some research has suggested that the number needed to treat for one patient to experience at least a 20% reduction in pain may be as high as 16.

    Click to Review



    8 . Which of the following studies regarding guidelines for the use of glucosamine and chondroitin in clinical practice is FALSE?
    A) The American College of Rheumatology (ACR) strongly recommends against the use of any glucosamine or chondroitin products for any form of osteoarthritis.
    B) The European Society of Clinical and Economic Aspects of Osteoarthritis (ESCEO) strongly recommends for the use of pharmaceutical-grade glucosamine sulfate or chondroitin sulfate products in patients with osteoarthritis.
    C) The ESCEO also provides a weak recommendation against the use of glucosamine and chondroitin in combination.
    D) The American College of Rheumatology (ACR) strongly recommends for glucosamine alone for knee osteoarthritis.

    REVIEWING THE EVIDENCE

    The American College of Rheumatology (ACR) strongly recommends against the use of any glucosamine or chondroitin products for any form of osteoarthritis. The European Society of Clinical and Economic Aspects of Osteoarthritis (ESCEO) strongly recommends for the use of pharmaceutical-grade glucosamine sulfate or chondroitin sulfate products in patients with osteoarthritis. The ESCEO also provides a weak recommendation against the use of glucosamine and chondroitin in combination [52,53].

    These conflicting recommendations are related to differing interpretations of the previously discussed evidence. The ACR has determined that the positive benefits identified in industry-funded studies evaluating pharmaceutical-grade products, as opposed to the conflicting findings identified with other products, indicates the introduction of industry bias [52].

    The ESCEO, on the other hand, has determined that the positive benefits identified in industry-funded studies evaluating pharmaceutical-grade products is due to the higher quality and bioavailability of the products used [1,53].

    Click to Review



    9 . Which single-ingredient supplement is least likely to be a concern in a patient with a shellfish allergy?
    A) Chondroitin sulfate
    B) Glucosamine hydrochloride
    C) Glucosamine sulfate
    D) N-acetyl glucosamine

    SAFETY CONSIDERATIONS

    Glucosamine is commonly derived from the exoskeletons of shrimp, lobster, and crabs. Thus, there is concern that the risk for hypersensitivity reactions to glucosamine may be greater in those with shellfish allergy [1].

    Shellfish allergies are caused by IgE-mediated reactions to antigens found in shellfish meat, not the exoskeleton. However, it is possible that allergen contamination can occur during manufacturing. Until more is known, use glucosamine with caution in these patients [1].

    Click to Review



    10 . Which of the following is among the most frequently reported adverse effects of chondroitin?
    A) Tachycardia
    B) Fatigue
    C) Abdominal pain
    D) Cognitive impairment

    SAFETY CONSIDERATIONS

    Chondroitin sulfate has been evaluated extensively in clinical research, with limited reports of adverse effects. When used in a dose of up to 2,000 mg daily for up to six years, it appears to be safe for most adults [61].

    The most frequently reported adverse effects include abdominal pain, bloating, constipation, diarrhea, heartburn, and nausea.

    Click to Review